Central Nervous System Stimulants: all 986 studies that test it
Page 10 of 10. Open to participants first (95), then studies with results posted, then the rest; newest registration first within each.
- Modafinil as an Adjunctive on Cognitive Functioning in Patients With SchizophreniaCompletedNCT00314639Phase 1/2
- Hepatic Drug Biotransformation in Children With Obstructive Sleep ApneaCompletedNCT00310323Not applicable
- Naturalistic Substitution of Concerta in Adult Subject With ADHD Receiving Immediate Release MethylphenidateCompletedNCT00302406Phase 4
- Study Examining Repeat Dosing of OROS® Methylphenidate (CONCERTA®) and Immediate Release Methylphenidate in Healthy AdultsCompletedNCT00302393Phase 3
- B181: Stimulation of Thermogenesis by Bio-Active Food IngredientsCompletedNCT00302289Phase 1
- A PET Study Examining Pharmacokinetics and Dopamine Transporter Receptor Occupancy Of Two Long-Acting Formulations of Methylphenidate in AdultsCompletedNCT00301639Phase 3
- Efficacy, Tolerability and Safety of Dexmethylphenidate HCl Extended-Release Capsules in Children With Attention-Deficit/Hyperactivity DisorderCompletedNCT00301236Phase 3
- Memory and Attention Problems in Lupus: New Treatment Trial With ModafinilTerminatedNCT00297284Not applicable
- Sequential Tranylcypromine (TC), TC + Dextroamphetamine and TC + Triiodothyronine for Refractory DepressionTerminatedNCT00296686Phase 4
- Ritalin: Antiasthenic Effect of Methylphenidate (Ritalin) in Palliative Care in Cancer PatientsTerminatedNCT00273741Phase 3
- Long-term Safety and Effectiveness of OROS Methylphenidate HCl in Children With Attention Deficit Hyperactivity DisorderCompletedNCT00269815Phase 3
- An Effectiveness and Safety Study Evaluating OROS Methylphenidate Hydrochloride (HCl), Ritalin (Methylphenidate HCl) and Placebo in Children With Attention Deficit Hyperactivity DisorderCompletedNCT00269776Phase 3
- Modafinil in Opioid Induced SedationTerminatedNCT00267332Phase 3
- Assessment of Interactions Between Intravenous Methamphetamine and Modafinil - 1Status unknownNCT00265278Phase 1
- Treatment of Orthostatic IntoleranceActive, not recruitingNCT00262470Phase 1/2
- Treatment of Patients With Alcoholism and Attention Deficit DisorderCompletedNCT00261872Phase 4
- Safety of Combining Modafinil and Nicotine Replacement Therapy in Treating Nicotine Dependent AdolescentsCompletedNCT00258479Phase 1
- Placebo-Controlled Comparison of Two Different Brands of Modified-Release Oral Dosage Forms Regarding Safety and Efficacy in Children With Attention Deficit Hyperactivity Disorder (ADHD) Aged 6 - 14CompletedNCT00254878Phase 3
- An Effectiveness and Safety Study of CONCERTA® (Methylphenidate Hydrochloride) in the Treatment of Adolescents With Attention Deficit Hyperactivity DisorderCompletedNCT00249353Phase 3
- Study to Evaluate the Likeability, Safety, and Abuse Potential of NRP 104 in Adults With Histories of Stimulant AbuseCompletedNCT00248092Phase 1/2
- Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse HistoriesCompletedNCT00247572Phase 2
- CONCERTA® (Methylphenidate Hydrochloride) as add-on Therapy in the Treatment of Adult Major Depressive Disorder.CompletedNCT00246233Phase 3
- A Study of the Effectiveness and Safety of Prolonged-release Methylphenidate Hydrochloride in Adult Patients With Attention Deficit/Hyperactivity Disorder.CompletedNCT00246220Phase 3
- CONCERTA (OROS Methylphenidate Hydrochloride) for the Treatment of Attention Deficit Hyperactivity Disorder in AdultsCompletedNCT00246207Phase 3
- Study to Assess Satisfaction With Modafinil Treatment in Children and Adolescents With ADHDCompletedNCT00228540Phase 3
- Treatment of Orthostatic Hypotension in Autonomic FailureCompletedNCT00223691Phase 1
- Methylphenidate and Driving Ability in Adult Patients With Attention-Deficit Hyperactivity DisorderCompletedNCT00223561Phase 4
- Fatigue Treatment Using ProvigilStatus unknownNCT00220506Not applicable
- Evaluation of Efficiency of Ritalin in Multiple Sclerosis (MS) PatientsStatus unknownNCT00220493Phase 1
- Treatment of Cocaine Dependence: Comparison of Three Doses of Dextro-Amphetamine Sulfate and PlaceboCompletedNCT00218348Phase 2
- Modafinil for Atypical DepressionCompletedNCT00215176Phase 2/3
- Evaluate the Safety and Efficacy of Modafinil in Children and Adolescents With ADHDCompletedNCT00214981Phase 3
- Assess the Safety and Effectiveness of PROVIGIL Treatment in Children and Adolescents With Excessive SleepinessCompletedNCT00214968Phase 3
- Combination Therapy (Provigil + Avonex) to Treat Cognitive Problems in MSStatus unknownNCT00210301Not applicable
- Provigil in Conjunction With SSRIs for the Treatment of Mild or Moderate Depression With Attendant Symptoms of Sleepiness and Fatigue.CompletedNCT00208715Phase 4
- Does Caffeine Affect the Sensitivity of Adenosine Perfusion Scans?CompletedNCT00205166Not applicable
- The Effect of Caffeine on Ischemic PreconditioningCompletedNCT00184912Not applicable
- Caffeine for Apnea of Prematurity (CAP)CompletedNCT00182312Phase 3
- Concerta in the Treatment of ADHD in Youth and Adults With Bipolar DisorderCompletedNCT00181987Phase 4
- A Double-Blind Comparison of Concerta and Placebo in Adults With Attention Deficit Hyperactivity DisorderCompletedNCT00181571Phase 4
- Modafinil to Reduce Persistent Fatigue in Patients Following Treatment for CancerCompletedNCT00178373Phase 2
- Provigil (Modafinil) Study by Taiwan Biotech Co.CompletedNCT00174174Not applicable
- NF1-Attention: Study of Children With Neurofibromatosis Type 1 Treated by MethylphenidateCompletedNCT00169611Phase 4
- Metabolic Capacity of Israeli PopulationsStatus unknownNCT00162383Not applicable
- Safety & Tolerability of MTS in Children Aged 6-12 Diagnosed With ADHD & Previously Treated With Extended-Release Methylphenidate TherapyCompletedNCT00151983Phase 3
- Efficacy, Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHDCompletedNCT00151970Phase 2
- Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD and Previously Participated in MTS TrialsCompletedNCT00151957Phase 3
- Modafinil in Multiple SclerosisCompletedNCT00142402Not applicable
- Safety and Efficacy Study of Dexmethylphenidate in Children With ADHDCompletedNCT00141063Phase 3
- Safety and Efficacy Study of Dexmethylphenidate in Children With ADHDCompletedNCT00141050Phase 3
- Psychostimulants for Fatigue in Prostate CancerCompletedNCT00138138Phase 2
- Methylphenidate Treatment for Cocaine Abuse and ADHD - 1CompletedNCT00136734Phase 1
- The Effects of Modafinil on Waking Function and on Sleep in Individuals With Primary InsomniaCompletedNCT00124384Phase 4
- Randomised Placebo-Controlled Trial of Modafinil for Cocaine DependenceStatus unknownNCT00123383Phase 2
- Trial of Modafinil for Methamphetamine DependenceStatus unknownNCT00123370Phase 2
- The Effect of Caffeine in Elderly CitizensCompletedNCT00117520Phase 4
- Modafinil in Treating Fatigue in Patients With CancerStatus unknownNCT00112515Not applicable
- PROVIGIL® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy or Obstructive Sleep Apnea/Hypopnea SyndromeCompletedNCT00107848Phase 3
- Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea SyndromeCompletedNCT00107809Phase 3
- Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With NarcolepsyCompletedNCT00107796Phase 3
- Modafinil for the Treatment of Cocaine Dependence - 1CompletedNCT00100100Phase 2
- Adderall XR Compared With Concerta in Treating Young Cancer Patients With Memory, Attention, and DepressionTerminatedNCT00069927Phase 2
- Modafinil to Treat Fatigue in Post-Polio SyndromeTerminatedNCT00067496Phase 3
- Treatment of Adult Attention Deficit Hyperactivity Disorder (ADHD) in Methadone Patients - 1CompletedNCT00061087Phase 2/3
- Effects of Modafinil on Brain Function in Patients With SchizophreniaCompletedNCT00057707Phase 1
- Modafinil in Treating Fatigue and Behavioral Change in Patients With Primary Brain CancerCompletedNCT00052286Not applicable
- D-MPH in the Treatment of Fatigue and Neurobehavioral Function Related to Chemotherapy in Adult Cancer PatientsCompletedNCT00047476Phase 2
- Modafinil in Treating Fatigue in Patients Receiving Chemotherapy for CancerCompletedNCT00042848Phase 3
- Pediatric Traumatic Brain Injury: Methylphenidate Effects on Early RecoveryCompletedNCT00035139Phase 4
- Evaluation of Modafinil as a Cocaine Treatment Medication and Interactions With Cocaine - 1Status unknownNCT00033046Phase 1
- Methylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain TumorsTerminatedNCT00031798Phase 3
- Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in ChildrenCompletedNCT00031395Phase 3
- Methylphenidate in Children and Adolescents With Pervasive Developmental DisordersCompletedNCT00025779Not applicable
- Treatment of Attention Deficit Hyperactivity Disorder in Preschool-Age Children (PATS)CompletedNCT00018863Phase 3
- Methylphenidate Raclopride Positron Emission Tomography (PET) Test - 11CompletedNCT00015301Phase 4
- Methylphenidate in the Treatment of Cocaine Dependent Patients With Adult Attention Deficit Hyperactivity Disorder - 5CompletedNCT00015223Phase 2
- Cocaine-Methylphendidate Interaction Study - 4CompletedNCT00015067Phase 1
- Methylphendidate Treatment of Cocaine Dependent Patients With Attention Deficit Hyperactivity Disorder - 3CompletedNCT00015054Phase 2
- Methylphenidate in Treating Patients With MelanomaCompletedNCT00003266Phase 3
- Pemoline in the Treatment of Stimulant Dependence - 5WithdrawnNCT00000340Phase 2
- Dextroamphetamine-Cocaine Behavioral Intervention - 5CompletedNCT00000308Phase 2
- Dextroamphetamine as Adjunct in Cocaine/Opiate Dependent Patients - 3CompletedNCT00000306Phase 2
- Amphetamine Cocaine Interaction Study - 2TerminatedNCT00000305Phase 1
- Dextroamphetamine as an Adjunct in Cocaine Treatment - 1CompletedNCT00000304Phase 2
- Pemoline for Cocaine Abuse - 7CompletedNCT00000282Phase 2
- Mazindol for Cocaine Abuse - 2CompletedNCT00000277Phase 2